Ftse Mib
33.324,01
1,26%
DAX
18.137,60
0,35%
S&P 500
0,00
0,00%
NASDAQ
17.857,02
0,95%
Bitcoin
65.274,45
-1,82%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Axcan Pharma (MM) (AXCA) Axcan Pharma (MM) (AXCA) Notizie

AXCA

Axcan Pharma (MM) (AXCA)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:AXCA
DataOraFonteTitoloSimboloCompagnia
25/02/200823:17Edgar (US Regulatory)Axcan Pharma Inc-Notification of removal from listing & reg. of matured, redeemed/retired sec. Initial Filing Amendme.. (25-NSE)NASDAQ:AXCAAxcan Pharma (MM)
19/02/200821:14Edgar (US Regulatory)Axcan Pharma Inc - Report of Foreign Issuer (6-K)NASDAQ:AXCAAxcan Pharma (MM)
14/02/200818:06Edgar (US Regulatory)Axcan Pharma Inc - Schedule 13G (SC 13G/A)NASDAQ:AXCAAxcan Pharma (MM)
13/02/200823:00MarketwiredAxcan and TPG Capital Receive Investment Canada Act Approval in Connection With Proposed AcquisitionNASDAQ:AXCAAxcan Pharma (MM)
13/02/200817:25Edgar (US Regulatory)Axcan Pharma Inc - Statement of Ownership (SC 13G)NASDAQ:AXCAAxcan Pharma (MM)
12/02/200822:59Edgar (US Regulatory)Axcan Pharma Inc - Amended Statement of Ownership (SC 13G/A)NASDAQ:AXCAAxcan Pharma (MM)
31/01/200813:00MarketwiredAxcan Pharma Reports Solid Start to Fiscal 2008, With Revenue of $92.9 Million in the First QuarterNASDAQ:AXCAAxcan Pharma (MM)
28/01/200818:25MarketwiredAxcan Pharma Inc.: Quebec Superior Court Issues Final Order Approving the Acquisition of Axcan by an Affiliate of TPG CapitalNASDAQ:AXCAAxcan Pharma (MM)
25/01/200816:37MarketwiredAxcan Shareholders Approve Acquisition by TPG Capital and its AffiliatesNASDAQ:AXCAAxcan Pharma (MM)
22/01/200819:00MarketwiredAxcan Pharma to Hold Special Meeting of Shareholders on January 25, 2008NASDAQ:AXCAAxcan Pharma (MM)
21/01/200814:30MarketwiredAxcan Pharma Announces Topline Financial Information for Q1 2008NASDAQ:AXCAAxcan Pharma (MM)
15/01/200815:00PR Newswire (US)Five Medical Technology Companies Host Premier Event for Cardiothoracic SurgeonsNASDAQ:AXCA
10/01/200822:46MarketwiredISS, PROXY Governance, Inc. and Glass, Lewis & Co. Recommend Shareholders Vote "FOR" the Proposed Acquisition of Axcan Pharma byNASDAQ:AXCAAxcan Pharma (MM)
10/01/200822:19MarketwiredAxcan and TPG Capital Receive Antitrust Clearances in Connection With the Proposed AcquisitionNASDAQ:AXCAAxcan Pharma (MM)
28/12/200723:24Edgar (US Regulatory)Axcan Pharma Inc - Annual Report (foreign private issuer) (40-F)NASDAQ:AXCAAxcan Pharma (MM)
21/12/200700:41MarketwiredCORRECTION FROM SOURCE: Axcan Pharma Inc. Obtains Interim Order for Proposed Arrangement and Announces Date of Special ShareholdNASDAQ:AXCAAxcan Pharma (MM)
21/12/200700:03MarketwiredAxcan Pharma Inc. Obtains Interim Order for Proposed Arrangement and Announces Date of Special Shareholder MeetingNASDAQ:AXCAAxcan Pharma (MM)
10/12/200715:48Edgar (US Regulatory)Axcan Pharma Inc - Statement of Beneficial Ownership (SC 13D)NASDAQ:AXCAAxcan Pharma (MM)
29/11/200717:34MarketwiredAxcan Updates on Upcoming Analyst and Investor EventsNASDAQ:AXCAAxcan Pharma (MM)
29/11/200714:40MarketwiredAxcan Pharma Inc. to be Acquired by TPG Capital and Affiliates for US$1.3 Billion or US$23.35 Per Share in CashNASDAQ:AXCAAxcan Pharma (MM)
29/11/200714:40MarketwiredAxcan Pharma Continues its Solid Growth Trend, Closing Fiscal 2007 With Record Annual Revenue of $348.9 Million, a 19.4% IncreasNASDAQ:AXCAAxcan Pharma (MM)
27/11/200721:00MarketwiredAxcan Pharma to Present at the BMO Capital Markets Focus on Healthcare ConferenceNASDAQ:AXCAAxcan Pharma (MM)
26/11/200720:00MarketwiredAxcan Pharma to Host Analyst and Investor Luncheon in New York on December 6, 2007NASDAQ:AXCAAxcan Pharma (MM)
19/11/200721:00MarketwiredAxcan Announces Conference Call and Webcast for Fourth Quarter and Fiscal 2007 ResultsNASDAQ:AXCAAxcan Pharma (MM)
02/10/200715:02Edgar (US Regulatory)Axcan Pharma Inc (Other) (6-K)NASDAQ:AXCAAxcan Pharma (MM)
11/05/200714:05PR Newswire (US)NicOx Provides an Update on the Phase 2a Study for NCX 1000 Conducted With AxcanNASDAQ:AXCA
22/06/200618:00PR Newswire (US)Model N Announces That Axcan Pharma Selects Both Commercial and Regulatory Model N Revenue Management ApplicationsNASDAQ:AXCA
10/05/200623:31PR Newswire (US)Axcan Pharma appoints new Senior Vice President and Chief Scientific OfficerNASDAQ:AXCAAxcan Pharma (MM)
04/05/200623:39PR Newswire (US)/FIRST AND FINAL ADD - MO124- AXCAN PHARMA INC./NASDAQ:AXCA
04/05/200623:38PR Newswire (US)Axcan announces record revenue of $72.8 million for the second quarter of fiscal 2006NASDAQ:AXCAAxcan Pharma (MM)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:AXCA

La tua Cronologia

EU
U348S
U348S
TG
GJZ
BWP
USOTC
ALLIF
Atlantic Lithium (QX)
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network